Andrew Levin
Angel · Massachusetts
Verified active in the last 12 months
Board director at 7 startups that filed Form D raises since late 2024, mostly in Massachusetts.
- Stages
- Series A to Growth
- Typical check (est.)
- Not disclosed
- Latest fund
- None on file
- Last verified activity
- Mar 2026
Focus
Biotech & PharmaRecent portfolio activity
Sources
- SEC Form D: Climb BioJul 2, 2024
- SEC Form D: Aktis OncologyOct 2, 2024
- SEC Form D: Imbria PharmaceuticalsApr 1, 2025
- SEC Form D: Pahr TherapeuticsJul 18, 2025
- SEC Form D: Lonestar MedicinesFeb 23, 2026
- SEC Form D: Solstice OncologyMar 9, 2026
Profile last verified Oct 12, 2026. Is this you? Correct or remove this profile.